A. Bibby

729 total citations
8 papers, 518 citations indexed

About

A. Bibby is a scholar working on Immunology, Dermatology and Physiology. According to data from OpenAlex, A. Bibby has authored 8 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Dermatology and 3 papers in Physiology. Recurrent topics in A. Bibby's work include Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (6 papers) and Asthma and respiratory diseases (3 papers). A. Bibby is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (6 papers) and Asthma and respiratory diseases (3 papers). A. Bibby collaborates with scholars based in United Kingdom, Australia and Spain. A. Bibby's co-authors include J. Decroix, W.S. Douglas, F. Cambazard, Knud Kragballe, M. de la Brassinne, Colin Fleming, Heikki Heikkilä, J. Toole, Gottfried Wozel and Joar Austad and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Addictive Behaviors.

In The Last Decade

A. Bibby

8 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Bibby United Kingdom	7	449	392	109	81	63	8	518
J. Toole Canada	10	214 0.5×	286 0.7×	52 0.5×	34 0.4×	46 0.7×	15	386
Teresa O'Sullivan United Kingdom	5	218 0.5×	182 0.5×	51 0.5×	37 0.5×	8 0.1×	6	303
Sanminder Singh United States	9	300 0.7×	169 0.4×	40 0.4×	25 0.3×	34 0.5×	15	430
N. Franzke Germany	9	131 0.3×	310 0.8×	15 0.1×	36 0.4×	44 0.7×	18	432
Jennifer Krejci-Manwaring United States	8	71 0.2×	314 0.8×	50 0.5×	20 0.2×	32 0.5×	16	443
AD Cohen Israel	7	309 0.7×	146 0.4×	57 0.5×	14 0.2×	50 0.8×	10	445
Heather Kornmehl United States	8	151 0.3×	145 0.4×	24 0.2×	17 0.2×	22 0.3×	11	310
Florian C. Beikert Germany	10	74 0.2×	203 0.5×	18 0.2×	21 0.3×	53 0.8×	18	291
Rachael Thorneloe United Kingdom	9	164 0.4×	96 0.2×	16 0.1×	33 0.4×	13 0.2×	13	310
Laëtitia Penso France	9	182 0.4×	124 0.3×	27 0.2×	11 0.1×	22 0.3×	16	380

Countries citing papers authored by A. Bibby

Since Specialization

Citations

This map shows the geographic impact of A. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bibby more than expected).

Fields of papers citing papers by A. Bibby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bibby. The network helps show where A. Bibby may publish in the future.

Co-authorship network of co-authors of A. Bibby

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bibby. A scholar is included among the top collaborators of A. Bibby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bibby. A. Bibby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Tyring, Stephen K., Natalia Mendoza, A. Bibby, et al.. (2010). A calcipotriene/betamethasone dipropionate two‐compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8‐week, double‐blind phase of a clinical trial. International Journal of Dermatology. 49(11). 1328–1333. 32 indexed citations

White, Stephen, et al.. (2006). Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??). American Journal of Clinical Dermatology. 7(3). 177–184. 27 indexed citations

Kragballe, Knud, Joar Austad, Larry D. Barnes, et al.. (2006). A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet^®/Daivobet^®/Taclonex^®) in the treatment of psoriasis vulgaris. British Journal of Dermatology. 154(6). 1155–1160. 113 indexed citations

Kragballe, Knud, Joar Austad, L. Barnes, et al.. (2006). Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris. Dermatology. 213(4). 319–326. 63 indexed citations

Anstey, Alex & A. Bibby. (2004). A pooled analysis of studies with a new calcipotriene/betamethasone two-compound product in psoriasis vulgaris. Journal of the American Academy of Dermatology. 50(3). P1–P1. 1 indexed citations

Douglas, W.S., Yves Poulin, J. Decroix, et al.. (2002). A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris. Acta Dermato Venereologica. 82(2). 131–135. 121 indexed citations

Kaufmann, Roland, A. Bibby, Robert Bissonnette, et al.. (2002). A New Calcipotriol/Betamethasone Dipropionate Formulation (Daivobet<sup>TM</sup>) Is an Effective Once-Daily Treatment for Psoriasis vulgaris. Dermatology. 205(4). 389–393. 127 indexed citations

Digiusto, Erol, et al.. (1996). Concordance between urinalysis results and self-reported drug use by applicants for methadone maintenance in Australia. Addictive Behaviors. 21(3). 319–329. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact